Divis laboratories News: Divis laboratories Latest News, Divis laboratories Today news, Divis laboratories Breaking News

A financial graphic focusing on the Nifty Healthcare Index breakout, showing technical chart setups for Torrent Pharma, Apollo Hospitals, Divi's Labs, and Mankind Pharma supporting the move towards 17,600, against a backdrop of a strong bullish weekly candle.

Monday Watchlist: Will short-covering extend Nifty’s rally? Torrent Pharma, Apollo Hospitals in focus

Nifty’s short-covering rally may extend as Metal and Healthcare flash bullish setups; watch Torrent Pharma, Apollo and key levels Monday.

August 3, 2026 05:30 IST

Dr Reddy’s, Sun Pharma, Divi’s go ex-dividend in July; check record dates and dividend payouts

Dr Reddy’s, Sun Pharma, Divi’s turn ex-dividend in July: Check full list and record dates

Sun Pharma, Dr Reddy’s, Zydus and Divi’s Labs turn ex-dividend in July as pharma stocks near highs; check record dates…

July 3, 2026 15:33 IST

Pharma stocks in focus: Jefferies bets on Sai Life Sciences and Divi’s Labs amid global supply chain reset

Sai Life, Divi’s Labs among Jefferies’ top CRDMO picks in India after US blacklists WuXi AppTe

US Department of Defense’s listing of Chinese firms as military-linked boosts prospects for Indian pharma CRDMOs like Sai Life Sciences…

June 11, 2026 14:17 IST

Pharma dividend watch: Abbott India, Torrent Pharma, Sun Pharma among 7 stocks with upcoming record dates

Pharma stocks including Abbott India, Sun Pharma, Torrent Pharma, Cipla and Divi’s Laboratories are in focus after announcing FY26 dividends…

Updated: May 25, 2026 07:55 IST

Q4FY26 earnings: Dividend King ITC, BPCL, IOC key stocks to watch – 600 companies to declare results this week

Corporate India is set for a packed Q4FY26 earnings week with 680 companies announcing results. Key names include ITC, BPCL,…

May 17, 2026 15:56 IST

GR Infraprojects executes Rs 413 crore NTPC battery storage project at Mouda plant

GR Infraprojects completes Rs 413 crore battery storage project for NTPC at Mouda plant.

April 24, 2026 11:15 IST

Government’s Rs 10,000 crore gambit to propel India into the global biologics league. (AI-generated image from Gemini)

India’s Rs 10,000 crore biologics boost: 3 CDMO stocks to watch as margins pivot

India’s ₹10,000 crore Biopharma SHAKTI scheme marks a definitive shift from low-cost generics to high-value biologics, aiming to integrate local…

April 11, 2026 05:30 IST

A technical stock market dashboard showing the FII long-short ratio at 16.8, with Sun Pharma and Tata Steel charts highlighting "Doji" and "Reversal" candlestick patterns near key support levels.

Monday Watchlist: Vedanta, Tata Steel, and 7 other stocks to watch – Small-caps show strength

Monday watchlist, April 05: Track Vedanta, Tata Steel, and top small-caps as technical trends signal possible short-term reversals—review market moves…

April 6, 2026 05:30 IST

A financial chart showing the India VIX surging to 27, its highest since the Russia-Ukraine war, alongside a list of oversold stocks like HDFC Bank and ICICI Bank poised for a relief rally.

Monday Watchlist: Sun Pharma, HDFC Bank, ICICI, and 7 stocks to watch – VIX hits 2-year high

Monday watchlist, March 30: Track Sun Pharma, HDFC Bank and ICICI as market volatility surges; review key stock setups and…

March 30, 2026 05:30 IST

Divis Labs GLP drug manufacturing opportunity

Divi’s Labs: Why the global GLP-1 ‘gold rush’ could spark a 36% rally

Divi’s Labs could emerge as a key beneficiary of the global GLP-1 drug boom, with new peptide manufacturing contracts and…

March 16, 2026 13:31 IST

5 Best Pharma CDMO Stocks in India to Add to Your Watchlist

Let’s take a look at 5 best CDMO pharma stocks in India.

March 11, 2026 13:35 IST

Nifty IT Index decline after AI disruption shock

Monday Watchlist: Is another downtrend looming as Nifty IT sinks 12%? Divi’s Lab, Apollo Hospitals and 7 stocks in focus

Nifty IT plunges 12%, raising downtrend fears as attention shifts to Divi’s Lab, Apollo Hospitals, and 7 key stocks; check…

February 16, 2026 05:30 IST

India's API powerhouses challenge China's dominance. (Image Source: Canva)

Beyond China: 3 Indian pharma stocks winning the global API war

APIs are a critical component in pharma manufacturing and nearly 65-70% of supplies in India come from China. The government…

December 20, 2025 05:30 IST

Divi’s, Syngene, Laurus and Cohance to lead India’s $15.4 billion CRDMO boom: JPMorgan

Divi’s, Syngene & Laurus: 6 stocks JPMorgan says will lead India’s $15.4 billion CRDMO boom

JPMorgan says India’s CRDMO market will grow to $15.4 billion by 2029, driven by China+1, regulatory edge and cost advantage,…

November 26, 2025 09:23 IST

Nuvama Equities's share price today, August 29

Nuvama’s ‘3’ buy recommendations, with 15% to 50% upside potential

Explore Nuvama’s top 3 stock picks—Divi’s Laboratories, Greenply Industries, Aditya Vision—with upside potential of up to 50%. Learn more now!

August 29, 2025 14:13 IST

Nuvama on Divi's Laboratories today, August 29

Nuvama sees 15% upside in this pharma stock: 3 reasons revealed

Nuvama on Divi’s Laboratories: Nuvama projects a 15% upside for Divi’s Laboratories; discover the three reasons behind this pharma stock’s…

August 29, 2025 08:46 IST

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Jefferies names Sai Life, Divi’s, and Cohance as top Indian CRDMO picks with up to 37% upside—see which pharma stocks…

August 26, 2025 12:18 IST

Nifty recovery, Trump tariff impact, profit booking

Market watchlist: From Vedanta, Adani Enterprise to Sun Pharma, 11 stocks set to see a turnaround

Track Nifty as Trump’s tariff threats shake its recovery, pharma rallies, and metals falter – see how markets may move…

Updated: August 25, 2025 23:27 IST

Divi's Laboratories Limited

Related News

Trending Topics